Key result
Aortic valve reconstruction with autologous pericardium in dialysis patients reduced peak pressure gradient from 66.0 mmHg preoperatively to 13.3 mmHg at 3 years, with no thromboembolic events.
Why the study?
Warfarin use in dialysis patients is problematic, and data on aortic valve reconstruction with autologous pericardium in this population are limited.
Does aortic valve reconstruction with autologous pericardium improve hemodynamics and clinical outcomes in dialysis patients?
Observational (n=54)
Does aortic valve reconstruction with autologous pericardium improve hemodynamics and clinical outcomes in dialysis patients?
Aortic valve reconstruction with autologous pericardium in dialysis patients provides excellent medium-term hemodynamics and avoids the need for postoperative warfarin.
May inform surgical options for dialysis patients with aortic valve disease; leaves open need for comparative prospective studies.
OBJECTIVES: This study aimed to report on original aortic valve reconstruction for patients on dialysis. METHODS: Aortic valve reconstruction has been performed on 404 cases from April 2007 through September 2011. Among them, 54 cases on haemodialysis were retrospectively studied. Forty-seven patients had aortic stenosis, 5 had aortic regurgitation (AR), and 2 had infective endocarditis. Mean age was 70.2 ± 8.5 years. There were 35 males and 19 females. There were 27 primary aortic valve reconstructions, 11 with CABG, 6 with ascending aortic replacement, 5 with mitral valve repair and 4 with maze. First, in the procedure, harvested pericardium was treated with 0.6% glutaraldehyde solution. After resecting the cusps, we measured the distance between commissures with original sizing instrument. Then, the pericardium was trimmed with the original template. Three cusps were sutured to each annulus. RESULTS: Peak pressure gradient averaged to 66.0 ± 28.2 mmHg preoperatively, and decreased to 23.4 ± 10.7, 13.8 ± 5.5 and 13.3 ± 2.3 mmHg, 1 week, 1 year, and 3 years after the operation, respectively. No calcification was detected with echocardiographic follow-up. Recurrence of AR was not recorded with the mean follow-up of 847 days except for 1 case reoperated on for infective endocarditis 2.5 years after the operation. Three hospital deaths were recorded due to non-cardiac causes. Other patients were in good condition. There was no thromboembolic event. CONCLUSIONS: Medium-term results are excellent. Since warfarin for dialysis patients becomes problematic, a postoperative warfarin-free status is desirable. Aortic valve reconstruction can provide patients with a better quality of life without warfarin.
No takes yet. Share an insight, caveat, or question.
Kawase et al. (2013) conducted an observational in Aortic valve disease in dialysis patients (n=54). Aortic valve reconstruction with autologous pericardium was evaluated on Peak pressure gradient. Aortic valve reconstruction with autologous pericardium in dialysis patients reduced peak pressure gradient from 66.0 mmHg preoperatively to 13.3 mmHg at 3 years, with no thromboembolic events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: